Expression of mouse mammary tumor virus superantigen accelerates tumorigenicity of myeloma cells

Journal of Virology

Volumn 74, Issue 18, 2000, Pages 8226-8233

  Umemura, M ^a   Wajjwalku, W ^a   Upragarin, N ^a   Liu, T ^a   Nishimura, H ^a   Matsuguchi, T ^a   Nishiyama, Y ^a   Wilson, G M ^a   Yoshikai, Y ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; HERMES ANTIGEN; HLA ANTIGEN CLASS 2; INTERLEUKIN 5; INTERLEUKIN 6; PADGEM PROTEIN; SUPERANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSFECTION; IN VITRO STUDY; LONG TERMINAL REPEAT; MALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MYELOMA CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; INTERLEUKIN-5; INTERLEUKIN-6; LEUKEMIA, MYELOID; MALE; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPERANTIGENS; TERMINAL REPEAT SEQUENCES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0033863968     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.18.8226-8233.2000     Document Type: Article

References (44)

1. Preferential expression of the T-cell receptor Vβ3 gene by Mlsc reactive T cells
2. Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary turnout virus
3. Exogenous and endogenous mouse mammary tumor virus superantigens
4. The primary in vivo immune response to Mls-1 (Mtv-7 sag). Route of injection determines the immune response pattern
5. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain
6. The use of an HTLV-I-infected human T-cell line (ATH8) in an interleukin-2 bioassay
7. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection
8. Further clonal expansion of T cells upon rechallenge of superantigen staphylococcal enterotoxin A
9. Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to propagate MMTV
10. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary turnout virus
11. Structural analysis of a mouse mammary tumor virus superantigen
12. Interleukin 3 is a growth factor for human follicular B cell lymphoma
13. Production of monoclonal antibodies: Strategy and tactics
14. Linkage of Mls genes to endogenous mammary tumor viruses of inbred mice
15. Biologic and molecular characterization of non-Hodgkin's lymphoma
16. Rat T cell responses to superantigens. II. Allelic differences in Vβ 8.2 and Vβ 8.5 β chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded products
17. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells
18. In vivo response of mature T cells to Mls(a) antigens. Long-term progeny of dividing cells include cells with a naive phenotype
19. Superantigens and retroviral infection: Insights from mouse mammary tumor virus
20. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus
21. An exogenous mouse mammary tumor virus with properties of Mls-1(a) (Mtv-7)
22. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex
23. + T cell clonotype
24. The mouse mammary turnout virus long terminal repeat encodes a type II transmembrane glycoprotein
25. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen
26. The structural basis of T cell activation by superantigens
27. a-encoded antigens
28. A maternally inherited superantigen encoded by a mammary tumour virus
29. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions
30. Mammary neoplasia in mice
31. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period
32. A new gene encoding the ligand for deletion oft cells bearing Tcrb-V6 and V8.1 (Mtv-50)
33. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode Vβ3-specific superantigens
34. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens
35. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
36. Modified acid guanidinium thiocyanate-phenol-chloroform RNA extraction method which greatly reduces DNA contamination
37. + T cells
38. I-E expression does not by itself influence growth of or T cell unresponsiveness to SJL lymphomas
39. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus
40. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo
41. T cells bearing Vβ8 are preferentially infected with exogenous mouse mammary tumor virus
42. A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection
43. A gene encoding the ligand for deletion oft cells bearing TcrVβ 6 and Vβ 8.1 cosegregates with a new endogenous mouse mammary tumor virus
44. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor Vβ specificity